Obermatt

Flags

Financial distress

Clorox

NYQ:CLX · US1890541097
Household ProductsLarge

360

8
EV / EBIT41
Price / Owner Earnings63
Owner Earnings Yield60
Dividend Yield99
Price/Sales69
EV / Gross Profit32
Price/Book1
Return on Capital80
Cash Return on Capital77
Return on Equity100
EBIT Margin63
Gross Profitability59
Cash Conversion11
Accruals16
Owner Earnings Margin68
Sales growth11
Profit Growth73
Long-Term EPS Growth3
Owner Earnings Growth37
Reinvestment11
Price momentum17
Debt load3
Refinancing26
Debt Payback24
Liquidity72
Analyst ratings1
Opinion Changes50
Price Target Upside26
Market mood27
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Clorox clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHousehold Products
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1986
Employees4,975
ISINUS1890541097
Last UpdateApr 2, 2026
Themes
LifestyleFast-Moving Consumer GoodsPet Food and SuppliesWater PurificationPet CareManufacturingMedical

Description

The Clorox Company operates as a multinational manufacturer and marketer of consumer and professional products. The company has operations in approximately 25 countries or territories and sells its products in approximately 100 markets, primarily th…

Analysis

Middle-of-the-road

The Clorox Company sits in the middle of our grid: average quality, average price, no obvious signal in either direction. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is fair. The owner-earnings multiple stands at 15.2×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 3% a year, against analyst forecasts of -4%. The gap between price and consensus is worth watching: demanding expectations.

Growth is weak; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
6
2023202420252026

All-time high

57

Jan 2024

All-time low

1

Jun 2025

Average rank

15

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
69
26
27
33
Price/Earnings
50
32
22
21
Price/Book
1
3
100
3
Dividend Yield
99
93
87
79
Value (overall)
82
51
23
20

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Clorox with its peers
Procter & Gamble Health
NSI:PGHL
72
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Minerals Technologies
NYQ:MTX
77
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
Hawkins
NSQ:HWKN
66
CountryUSA
IndustryChemicals
SizeMedium
Full Stock Analysis →
Ashland
NYQ:ASH
7
CountryUSA
IndustryChemicals
SizeLarge
Full Stock Analysis →
USANA Health Sciences
NYQ:USNA
96
CountryUSA
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
International Flavors & Fragrances
NYQ:IFF
42
CountryUSA
IndustryChemicals
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →